Teva Pharmaceutical Industries Limited (TLV:TEVA)
| Market Cap | 30.65B |
|---|---|
| Revenue | 0 |
| Gross Profit | 0 |
| Shares Out | 1.11B |
| EPS (ttm) | |
| PE Ratio | 0.0000 |
| Forward PE | 0.0000 |
| Dividend Rate (ttm) | 0.0000 |
| Dividend Yield | 0.0000 |
| Trading Day | Jun 13 |
|---|---|
| Last Price | ₪27.60 |
| Previous Close | ₪27.60 |
| Change (₪) | 0 |
| Change (%) | 0% |
| Day's Open | 27.6 |
| Day's Range | 27.6 - 27.6 |
| Day's Volume | 0 |
| 52 Week Range | 24.02 - 36.15 |
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd. has been developing and producing medicines to improve people's lives for more than a century.
It is a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry.
Along with its established presence in generics, it has significant innovative research and operations supporting its growing portfolio of specialty and biopharmaceutical products.
News
Quick info
P O B 3190
Petah Tikva
49131
Teva Pharmaceutical Industries Limited dividends
Total Valuation
Teva- Pharmaceutical Industries Ltd. has a market cap or net worth of ₪30.65 billion. The enterprise value is ₪0.
Important Dates
Share Statistics
Teva- Pharmaceutical Industries Ltd. has 1.11 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Teva- Pharmaceutical Industries Ltd.'s PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0701%. The beta is 0.0000, so Teva- Pharmaceutical Industries Ltd.'s price volatility has been lower than the market average.
Income Statement
In the last 12 months, Teva- Pharmaceutical Industries Ltd. had revenue of ₪0 and earned ₪0 in profits. Earnings per share was ₪.